Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 601 30 801.8 |
96 | EP file number | EAKZ | 01 96 5984.6 |
86 | WO file number | WAKZ | PCT/US01/25803 |
97 | EP publication number | EPN | 1355631 |
87 | WO publication number | WPN | 2002015885 |
54 | Designation/title | TI | IN DER MUNDHÖHLE SCHNELL ZERFALLENDE ORALE ARZNEIZUBEREITUNG ENTHALTEND EINEN CYCLOOXYGENASE-2 HEMMER |
51 | IPC main class | ICM (ICMV) | A61K 9/20 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/635 (2006.01) |
22 | DE application date | DAT | Aug 17, 2001 |
96 | EP application date | EAT | Aug 17, 2001 |
86 | WO application date | WAT | Aug 17, 2001 |
43 | Date of first publication | OT | Feb 28, 2002 |
| Date of publication of grant | PET | Oct 3, 2007 |
71/73 | Applicant/owner | INH | Astellas Pharma Technologies, Inc. (n.d.Ges.d.Staates Delaware), Norman, Okla, US; Pharmacia Corp., North Peapack, N.J., US |
72 | Inventor | IN | LE, Trang, T., Mundelein, IL 60060, US; KARARLI, Tugrul, T., Skokie, IL 60076, US; KONTNY, Mark, J., Libertyville, IL 60048, US; SASTRY, Srikonda, V., Sunnyvale, CA 94087, US; NYSHADHAM, Janaki, R., Fremont, CA 94539, US; PAGLIERO, Arthur, J., Vacaville, CA 94303, US |
74 | Representative | VTR | Kraus & Weisert Patentanwälte PartGmbB, 80539 München, DE |
10 | Published DE documents | DEPN | Original document:
DE000060130801T2 Searchable text:
DE000060130801T2 |
| Address for service | | Kraus & Weisert Patentanwälte PartGmbB, 80539 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 226347 P Aug 18, 2000
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
87 | WO language of publication | WLANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR |
81 | Designated WO countries | WDS | LT, SI, AL, LV, MK, RO |
| Published EP/WO documents | EPWOPN | Original document:
EP000001355631 Searchable text:
EP000001355631 Original document:
EP000001355631B1 Searchable text:
EP000001355631B1 Original document:
WO002002015885 Searchable text:
WO002002015885 |
43 | Date of first publication | EVT | Feb 28, 2002 |
| Date of the first transfer into DPMAregister | EREGT | Sep 29, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Oct 25, 2018 (Show all update days)(Hide all update days)- Oct 25, 2018; Aug 25, 2015; Mar 31, 2015; Jan 25, 2013
- Historical data not available for this/these date(s)
- Sep 29, 2012
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 5)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Sep 6, 2007 |
| Issue number | HN | 22 |
| Year | PJ | 2008 |
| Publication date | VT | May 29, 2008 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Pharmacia Corp., North Peapack, N.J., US; Yamanouchi Pharma Technologies, Inc., Palo Alto, Calif., US |
71/73 | Previous applicant/owner | INHF | Pharmacia Corp., St. Louis, Mo., US, Yamanouchi Pharma Technologies, Inc., Palo Alto, Calif., US |
View procedures New applicant/owner details (No.: 8)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Mar 20, 2008 |
| Issue number | HN | 22 |
| Year | PJ | 2008 |
| Publication date | VT | May 29, 2008 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Astellas Pharma Technologies, Inc. (n.d.Ges.d.Staates Delaware), Norman, Okla, US; Pharmacia Corp., North Peapack, N.J., US |
71/73 | Previous applicant/owner | INHF | Pharmacia Corp., North Peapack, N.J., US, Yamanouchi Pharma Technologies, Inc., Palo Alto, Calif., US |